Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Top Cited Papers
- 3 April 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 55 (5), 105960
- https://doi.org/10.1016/j.ijantimicag.2020.105960
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding PeptidePLOS ONE, 2014
- Sialic Acid Receptors of VirusesTopics in current chemistry, 2013
- Drug repurposing programmes get lift offNature Reviews Drug Discovery, 2012
- Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseasesExpert Reviews in Molecular Medicine, 2010
- Additive empirical force field for hexopyranose monosaccharidesJournal of Computational Chemistry, 2008
- Lipid rafts are involved in SARS-CoV entry into Vero E6 cellsBiochemical and Biophysical Research Communications, 2008
- Prediction of Glycolipid-Binding Domains from the Amino Acid Sequence of Lipid Raft-Associated Proteins: Application to HpaA, a Protein Involved in the Adhesion of Helicobacter pylori to Gastrointestinal CellsBiochemistry, 2006
- New insights into the antiviral effects of chloroquineThe Lancet Infectious Diseases, 2006
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 ProteinsPublished by Elsevier BV ,2002